Molecular diagnostic device
Latest NUCLEIN, LLC Patents:
Description
The broken lines depict portions of the molecular diagnostic device that form no part of the claimed design.
Claims
We claim an ornamental design for a molecular diagnostic device, as shown and described.
Referenced Cited
U.S. Patent Documents
Other references
D494279 | August 10, 2004 | Cogan |
D522145 | May 30, 2006 | Best |
D743571 | November 17, 2015 | Jackson |
D790074 | June 20, 2017 | Fuller |
D895139 | September 1, 2020 | Hong |
D908884 | January 26, 2021 | Yamakawa |
D921918 | June 8, 2021 | Eriksson |
D923196 | June 22, 2021 | Fang |
D932049 | September 28, 2021 | Kuroda |
20190150836 | May 23, 2019 | Skafidas |
- NS Medical Device. Nuclein secures $14m funding to commercialise hand-held PCR device. Published on Mar. 26, 2021. Retrieved from internet on Jun. 3, 2022 at: https://www.nsmedicaldevices.com/Industry_taxonomy/Devices/.
Patent History
Patent number: D977138
Type: Grant
Filed: Nov 17, 2020
Date of Patent: Jan 31, 2023
Assignee: NUCLEIN, LLC (Austin, TX)
Inventors: Richard Crockett (Austin, TX), Alan Blake (Austin, TX), Kevin Brase (Georgetown, TX), Ehren Achee (Spicewood, TX), Douglas Hammond (Pflugerville, TX)
Primary Examiner: Anhdao Doan
Application Number: 29/758,633
Type: Grant
Filed: Nov 17, 2020
Date of Patent: Jan 31, 2023
Assignee: NUCLEIN, LLC (Austin, TX)
Inventors: Richard Crockett (Austin, TX), Alan Blake (Austin, TX), Kevin Brase (Georgetown, TX), Ehren Achee (Spicewood, TX), Douglas Hammond (Pflugerville, TX)
Primary Examiner: Anhdao Doan
Application Number: 29/758,633
Classifications
Current U.S. Class:
Specimen Handling, Preparation Or Testing (62) (D24/216)